Pharmaceutical and Medical Device Development
| Unit of study | Credit points | A: Assumed knowledge P: Prerequisites C: Corequisites N: Prohibition | Session |
|---|---|---|---|
Pharmaceutical and Medical Device Development |
|||
Master of Medicine (Pharmaceutical and Medical Device Development) |
|||
Master of Science in Medicine (Pharmaceutical and Medical Device Development) |
|||
| Students must complete 48 credit points, including: | |||
| (a) 12 credit points of compulsory units of study; and | |||
| (b) 24 credit points of stream specific units of study; and | |||
| (c) 12 credit points of stream specific or general elective units of study. | |||
Master of Medicine (Advanced) (Pharmaceutical and Medical Device Development) |
|||
Master of Science in Medicine (Advanced) (Pharmaceutical and Medical Device Development) |
|||
| Students must complete 60 credit points, including: | |||
| (a) 48 credit points of study as required for the Master of Medicine/Master of Science in Medicine | |||
| (b) 12 credit points of project units of study. | |||
Graduate Diploma in Medicine (Pharmaceutical and Medical Device Development) |
|||
Graduate Diploma in Science in Medicine (Pharmaceutical and Medical Device Development) |
|||
| Students must complete 36 credit points, including: | |||
| (a) 6 credit points of compulsory units of study; and | |||
| (b) 24 credit points of stream specific units of study; and | |||
| (c) 6 credit points of stream specific or general elective units of study. | |||
Graduate Certificate in Medicine (Pharmaceutical and Medical Device Development) |
|||
Graduate Certificate in Science in Medicine (Pharmaceutical and Medical Device Development) (admission suspended) |
|||
| Students must complete 24 credit points, including: | |||
| (a) 24 credit points of stream specific units of study. | |||
Compulsory units |
|||
Compulsory units - Graduate Diploma, Graduate Diploma in Science |
|||
| CEPI5100 Introduction to Clinical Epidemiology |
6 | N PUBH5010 It is recommended that this is completed as soon as possible after enrolment into your first unit of study. |
Semester 1 Semester 2 |
Compulsory units - Master of Medicine, Master of Science in Medicine, Master of Medicine (Advanced) |
|||
| CEPI5100 Introduction to Clinical Epidemiology |
6 | N PUBH5010 It is recommended that this is completed as soon as possible after enrolment into your first unit of study. |
Semester 1 Semester 2 |
| PCOL5104 Pharm and Medical Device Development |
6 | C CEPI5100 and 18 credit points of stream specific units of study from any of (PCOL5101, PCOL5102, PCOL5103, PCOL5105, PHAR7815) |
Semester 2 |
Stream specific units |
|||
| PCOL5101 Drugs and Devices: R and D to Registration |
6 | Semester 1 |
|
| PCOL5102 Modern Therapeutics and Medical Devices |
6 | Semester 2 |
|
| PCOL5103 Therapeutics and Device Innovations (Project) |
6 | C PCOL5101 or PCOL5102 |
Semester 1 |
| PCOL5105 Commercialising MedTech and Pharma |
6 | Semester 2 |
|
| PHAR7815 Regulation of Complementary Medicines |
6 | A Students will be expected to have a relevant health care, health science or science related undergraduate qualification or experience working in this sector. |
Semester 1 |
General elective units |
|||
| BETH5104 Bioethics, Law and Society This unit of study is not available in 2020 |
6 |
Prerequisites: A three-year undergraduate degree in science, medicine, nursing, allied health sciences, philosophy/ethics, sociology/anthropology, law, history, or other relevant field, or by special permission. |
Semester 1 |
| BETH5209 Medicines Policy, Economics and Ethics |
6 | A A degree in science, medicine, pharmacy, nursing, allied health, philosophy/ethics, sociology/anthropology, history, law, communications, public policy, business, economics, commerce, organisation studies, or other relevant field, or by special permission. |
Semester 2 |
| BSTA5003 Health Indicators and Health Surveys |
6 | C BSTA5001 |
Semester 1 |
| CEPI5200 Quality and Safety in Health Care |
6 |
People working in health care will benefit from this course. |
Semester 1 |
| CEPI5215 Writing and Reviewing Medical Papers |
6 | A Some basic knowledge of summary statistic is assumed P (PUBH5010 or CEPI5100) N CEPI5214 Students without the pre-requisites are encouraged to contact the Unit Coordinator to discuss their motivation and experience. |
Semester 1 Semester 2 |
| CEPI5312 Diagnostic and Screening Tests (1 and 2) |
6 | P PUBH5010 or CEPI5100 N PUBH5208 or CEPI5202 or CEPI5311 |
Semester 2 |
| CEPI5315 Introduction to Systematic Reviews |
6 | C CEPI5100 or PUBH5010 N CEPI5203 or CEPI5102 or CEPI5314 |
Semester 1 |
| CLTR5001 Trial Design and Methods |
6 | Semester 1 |
|
| CLTR5004 Advanced Trial Design |
6 | P CLTR5001 and CLTR5007 |
Semester 2 |
| HPOL5001 Health Systems and Financing |
6 | N GLOH5135 |
Semester 1 |
| HPOL5006 Business of Health |
6 | Intensive July |
|
| PUBH5018 Introductory Biostatistics |
6 | Semester 1 |
|
| PUBH5422 Health and Risk Communication |
6 | Semester 1 |
|
| WARC5001 Research Translation, Impact and Evaluation |
6 | A An understanding of research methodology and clinical trials is assumed. |
Semester 2 |
Project units of study |
|||
| MEDF5301 Project (Advanced Masters) |
12 |
Approval of the project and supervisor by the Program Director must be confirmed prior to commencing the project. |
Semester 1 Semester 2 |
| MEDF5302 Project (Advanced Masters) (Part A) |
6 |
Approval of the project and supervisor by the Program Director must be confirmed prior to commencing the project. |
Semester 1 Semester 2 |
| MEDF5303 Project (Advanced Masters) (Part B) |
6 |
Approval of the project and supervisor by the Program Director must be confirmed prior to commencing the project. |
Semester 1 Semester 2 |